Company Hyphens Pharma International Limited

Equities

1J5

SG1EE4000006

Pharmaceuticals

Market Closed - Singapore S.E. 11:25:03 2024-04-18 pm EDT 5-day change 1st Jan Change
0.27 SGD -1.82% Intraday chart for Hyphens Pharma International Limited 0.00% -5.26%

Business Summary

Hyphens Pharma International Limited is a Singapore-based specialty pharmaceutical and consumer healthcare company. The Company's principal activities are those of an investment holding company and provision of management services. The Company's segments include Specialty pharma principals, Proprietary brands, and Medical hypermart and digital. The Specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The Proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The Medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position themselves as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.

Number of employees: 355

Sales per Business

SGD in Million2022Weight2023Weight Delta
Specialty Pharma Principals
59.9 %
96 58.9 % 102 59.9 % +6.83%
Medical Hypermart and Digital
25.1 %
43 26.6 % 43 25.1 % -1.09%
Proprietary Brands
15.0 %
23 14.4 % 26 15.0 % +9.45%

Sales per region

SGD in Million2022Weight2023Weight Delta
Singapore
49.8 %
85 52.1 % 85 49.8 % +0.53%
Vietnam
28.7 %
55 33.6 % 49 28.7 % -10.15%
Others
11.3 %
8 5.0 % 19 11.3 % +139.13%
Malaysia
10.1 %
15 9.3 % 17 10.1 % +13.90%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 97-12-31
Director of Finance/CFO - 22-12-31
Chief Operating Officer 59 19-08-31
Corporate Officer/Principal - 05-12-31
General Counsel - 96-12-31
Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 59 18-04-22
Director/Board Member 52 20-11-04
Chief Executive Officer 56 97-12-31
Director/Board Member 57 17-12-11
Director/Board Member 54 18-04-22
Director/Board Member 64 19-07-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 309,198,000 56,086,600 ( 18.14 %) 0 18.14 %

Shareholders

NameEquities%Valuation
147,656,441 47.75 % 29 M $
86,635,759 28.02 % 17 M $
4,172,900 1.350 % 819 349 $
4,122,900 1.333 % 809 531 $
Nikko Asset Management Asia Ltd.
1.294 %
4,000,400 1.294 % 785 479 $
1,838,400 0.5946 % 360 970 $
Eng Sai Ong
0.5854 %
1,810,000 0.5854 % 355 394 $
Poh Lim Ong
0.4966 %
1,535,600 0.4966 % 301 515 $
Phillip Capital Management (S) Ltd.
0.4033 %
1,247,000 0.4033 % 244 848 $
1,100,000 0.3558 % 215 985 $

Holdings

NameEquities%Valuation
471,200 0.15% 92,520 $

Company contact information

Hyphens Pharma International Ltd.

16 Tai Seng Street Level 4

534138, Singapore

+

http://www.hyphensgroup.com
address Hyphens Pharma International Limited(1J5)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.27 SGD
Average target price
0.35 SGD
Spread / Average Target
+29.63%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1J5 Stock
  4. Company Hyphens Pharma International Limited